The Gross Law Firm Announces Important Deadline for Capricor Therapeutics Shareholders in Class Action Lawsuit
Reminder for Capricor Therapeutics Shareholders
In a significant update for investors of Capricor Therapeutics, Inc. (NASDAQ: CAPR), The Gross Law Firm has alerted shareholders about an important deadline related to a class action lawsuit involving the company. Shareholders who acquired CAPR shares between October 9, 2024, and July 10, 2025, are encouraged to register for potential lead plaintiff status.
Background of the Lawsuit
The legal action stems from allegations regarding misleading information provided by Capricor management about its lead cell therapy candidate, deramiocel. This investigational drug is designed for the treatment of Duchenne muscular dystrophy (DMD), a severe muscle-wasting disease. The complaint asserts that while the company communicated an optimistic outlook regarding obtaining a Biologics License Application (BLA) from the FDA, it simultaneously withheld critical safety and efficacy data resulting from a four-year study.
On July 11, 2025, Capricor announced they received a Complete Response Letter (CRL) from the FDA, indicating that they had not met the required statutory standards for demonstrating sufficient evidence of effectiveness for deramiocel, necessitating further clinical data. This news had an immediate and adverse impact, causing the stock price to plummet from $11.40 to $7.64 in a single day.
Importance of Registration
The Gross Law Firm urges affected shareholders to register their information promptly to ensure their rights are preserved and to receive regular updates about the status of the case. Enrollees will be included in a portfolio monitoring system that provides ongoing information about the progression of legal proceedings.
Deadline and Next Steps
To become a lead plaintiff and participate in potential recovery, shareholders must submit their registration by September 15, 2025. It's important to note that there is no obligation or cost to join the lawsuit. Interested parties can follow this link to register.
About The Gross Law Firm
The Gross Law Firm is nationally recognized for its commitment to protecting investors' rights. The firm's mission focuses on seeking justice for those who have suffered losses due to misleading information and unethical business practices. With a strong reputation for pursuing class action lawsuits, the firm is dedicated to holding corporations accountable for their actions.
For more information, potential claimants can contact The Gross Law Firm at (646) 453-8903 or visit their official website for further resources.
This reminder serves as a vital opportunity for Capricor shareholders to take action as the deadlines approach, ensuring they can pursue possible recoveries from investment losses resulting from the recent setbacks of Capricor Therapeutics.
Contact Details:
The Gross Law Firm
15 West 38th Street, 12th Floor,
New York, NY, 10018
Email: [email protected]
Topics Financial Services & Investing）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.